Separating 'Facts' From 'Guidance'

 | Jan 23, 2013 | 11:50 AM EST  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

mcd

,

txn

,

ph

,

abt

,

gd

,

coh

,

kors

People need a thesis, and they grab at any thesis to make a capital commitment. At the opening today we saw buyers rush into McDonald's (MCD) despite very tepid guidance. Why? Because it was down a lot last year and because the printed number, the number reported, was indeed better than expected.

Here's the deal: I don't think it is enough that a stock is behind the market or that it just beats numbers.

You need the guidance to be good.

That's why I don't trust McDonald's at all. I think you are going to see multi-month disappointments and you have no way out once you get in.

I feel the same way about Texas Instruments (TXN). Here the company said things are getting better, but still guided below the street.

That just doesn't cut it.

The only group of stocks that has been immune from "the facts" and "the guidance," so to speak, has been the industrials. Go listen to Parker-Hannifin (PH). It reported a terrible quarter that got worse as it went along. The company was cautious, yet the stock still went higher. Why? I think because the big industrials are getting the benefit of the doubt that the world's economies are turning stronger.

But when a company has a secular, declining end of its business, as we see with Texas Instruments, or difficult comparisons, as we see in McDonald's, the movements upward tend to be false. They are selling, not buying, opportunities.

Random Musings: We have a good video out about how Abbott Labs (ABT) should be bought, one of our favorite ActionAlertsPlus names ... The defense stocks aren't immune after all, bad shortfall from General Dynamics (GD) ... Very concerned with Coach (COH) and really do believe it has gotten old. I think Michael Kors (KORS) is cutting into their business. Trees do not grow to the sky.

Columnist Conversations

Index Chart of the Day: SPX and RUT Divergence SPX vs. RUT (YTD) View Chart »&nbs...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
The S&P 500 index finished the week unchanged, but the VIX was up 5%, the divergence sending a bit of a mi...
Weyerhaeuser has been struggling since testing the 2013 highs last month. The stock extended a powerful...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.